COMMON SHARE PURCHASE WARRANTS. THIS IS TO CERTIFY THAT for value received ● (the “Holder”) is the registered holder of the number of warrants (the “Warrants”) stated above and is entitled, for each whole Warrant represented hereby, to purchase one Common Share (subject to adjustment as hereinafter referred to) in the capital of Titan Medical Inc. (the “Company”) at any time from the date of issue hereof up to and including 5:00 p.m. (Toronto Time) on March 31, 2021 (the “Expiry Time”) by surrendering to Computershare Trust Company of Canada (the “Warrant Agent”) at its principal transfer office in Toronto, Ontario this Warrant Certificate with a subscription in the form of the attached Subscription Form duly completed and executed and accompanied by payment of CDN$1.20 per share, subject to adjustment as hereinafter referred to (the “Exercise Price”) by certified cheque, money order or bank draft in lawful money of Canada payable to or to the order of the Company at par in Xxxxxxx, Xxxxxxx. The Holder may purchase less than the number of Common Shares which the Holder is entitled to purchase on the exercise of the Warrants represented by this Warrant Certificate, in which event a new Warrant Certificate representing the Warrants not then exercised will be issued to the holder. The Warrants represented by this Warrant Certificate shall be deemed to have been surrendered and payment by certified cheque, money order or bank draft shall be deemed to have been made, only upon personal delivery thereof or, if sent by post or other means of transmission, upon actual receipt thereof by the Warrant Agent at the office specified above. This Warrant Certificate represents Warrants issued under the provisions of the Warrant Indenture (which indenture together with all other instruments supplemental or ancillary there is referred to herein as the “Warrant Indenture”) dated as of March 31, 2016 between the Company and the Warrant Agent, which contains particulars of the rights of the holders of the Warrants and the Company and of the Warrant Agent in respect thereof and the terms and conditions upon which the Warrants are issued and held, all to the same effect as if the provisions of the Warrant Indenture were herein set forth, to all of which the holder of this Warrant Certificate by acceptance hereof assents. A copy of the Warrant Indenture is available for inspection on the Company’s profile on xxx.xxxxx.xxx or the Company shall, on the written request of the Holder and without charge, provide th...
COMMON SHARE PURCHASE WARRANTS. A" ---------------------------------- ENTREE GOLD INC. (the "Company") This certificate (the "Warrant Certificate") is to certify that, for value received, KENNECOTT CANADA EXPLORATION INC. (the "Warrant Holder") is the holder of 641,191 common share purchase warrants "A" (the "Warrants") of the Company. For each TWO (2) Warrants, the Warrant Holder has the right to purchase from the Company, upon and subject to the terms and conditions hereinafter referred to, ONE (1) common share without par value (individually, a "Share" and collectively, the "Shares") in the capital of the Company. The Shares may be purchased hereunder at a price of $2.75 (Canadian) per Share unless otherwise adjusted pursuant to the terms hereof (the "Exercise Price"), at any time up to 5:00 p.m. local time in Vancouver, British Columbia on July 6, 2007. The right to purchase the Shares may be exercised in whole or in part, by the Warrant Holder only, at the Exercise Price within the times set forth above by:
COMMON SHARE PURCHASE WARRANTS. Each Warrant will entitle the holder thereof to purchase one additional common share in the capital of the Corporation (a “Warrant Share”) at an exercise price of $0.50 per Warrant Share to the extent such Warrant is exercised on or before the date that is 24 months from the Closing Date (as hereinafter defined). In the event that after four months and one day after the Closing Date, the closing price of the Corporation's common shares on the TSX Venture Exchange (or such other stock exchange on which the Corporation's shares are listed and where a majority of the trading volume occurs), for a period of ten (10) consecutive trading days equals or exceeds $0.75 per common share, the Corporation may, within five (5) days after such an event, provide notice to the warrant holders of early expiry of the Warrants held by each warrant holder and thereafter, such Warrants will expire at 3:30 p.m. (Toronto time) on the date which is twenty-one (21) days after the date of the notice to the warrant holders. ISSUE PRICE: CDN$0.30 per Unit. SIZE OF THE OFFERING: Up to an aggregate of $3,000,000. FINANCIAL ADVISORY AGREEMENT: In the event the Offering is successfully completed raising not less than $2,500,000 in aggregate gross proceeds, the Agent, the Corporation, and Canaccord agree to enter into a mutually acceptable financial advisory agreement (the "Advisory Agreement") whereby the Agent and Canaccord will act, for a period of 24-months following the Closing Date, as a financial advisor to the Corporation. The terms of the Advisory Agreement will be negotiated in good faith between the parties prior to the Closing Date.
COMMON SHARE PURCHASE WARRANTS. Each whole Warrant will entitle the holder to acquire one Share from the Company at a price of US$12.60 per Share for a period of 36 months following Closing.
COMMON SHARE PURCHASE WARRANTS. Each Common Share Purchase Warrant will entitle the holder to buy one Common Share at the exercise price of $0.60 during the first year from completion of the financing, $0.80 during the second year and at an exercise price of $1.00 during the third year. The three year term of the warrants is conditional upon Rockwell achieving Tier 1 status on the TSX Venture Exchange within the first two years. Type of Transaction: “Best Efforts” offering by way of private placement subject to the terms and conditions of the agency agreement. The offering is subject to the private placement requirements of the provinces of Ontario, Alberta and British Columbia, including completion of appropriate forms and private placement commitment letters. The Units may be sold in the United States by private placement and will be available for re-sale under Rule 904 of Regulation S or Rule 144 of the United States Securities Act of 1933. Offering Price: $0.50 per Unit.
COMMON SHARE PURCHASE WARRANTS. The Company has 45,005,805 common share purchase warrants outstanding, each exercisable for one Common Share, as follows: Number Granted Exercise Price ($) Expiry Date 8,333,334 0.05 December 6, 2021 84,000 0.05 December 6, 2021 31,369,224 0.08 February 28, 2022 461,538 0.08 February 28, 2022 4,613,527 0.35 May 20, 2022 144,182 0.35 May 20, 2022 45,005,805 SCHEDULE “B” COMPLIANCE WITH UNITED STATES SECURITIES LAWS This is Schedule “B” to the agency agreement dated as of September 30, 2020 between the Company and the Agent. Capitalized terms used herein and not defined herein shall have the meanings ascribed thereto in the Agency Agreement to which this Schedule “B” is annexed. The following terms shall have the meanings indicated:
